GMED - Globus Medical, Inc.
Price:
--
--
|
CONSENSUS:
Buy
DETAILS
|
PRICE TARGET:
$98.88
DETAILS
HIGH:
$117.00
LOW:
$80.00
MEDIAN:
$100.00
CONSENSUS:
$98.88
UPSIDE:
34.42%
Institutional Holders (13F)
| GURU | SHARES | VALUE | WEIGHT % | SHARES CHG | ACTION |
|---|---|---|---|---|---|
| Dalio | 351,974 | $27.8M | 0.1% | +21,511 | INCREASED |
| Greenblatt | 283,058 | $22.4M | 0.1% | +133,955 | INCREASED |
| Cooperman | 8,300 | $655,783 | 0.0% | -20,059 | DECREASED |
Insider Trading
| DATE | INSIDER | TITLE | TYPE | SHARES | PRICE | VALUE |
|---|---|---|---|---|---|---|
| 2026-08-18 | ZARRILLI STEPHEN T | director | M-Exempt | 25,000 | $53.27 | $1.3M |
| 2026-08-18 | ZARRILLI STEPHEN T | director | SELL | 25,000 | $87.04 | $2.2M |
| 2026-07-27 | Davidar David D | director | G-Gift | 2,500 | -- | -- |
| 2026-06-05 | Davidar David D | director | SELL | 25,000 | $80.76 | $2.0M |
| 2026-06-05 | Davidar David D | director | M-Exempt | 25,000 | $26.27 | $657K |
| 2026-06-04 | RHOADS ANN D | director | M-Exempt | 25,000 | $26.27 | $657K |
| 2026-02-25 | Huller Kelly | officer: EVP, GC, Corporate Secretary | M-Exempt | 20,000 | $43.58 | $872K |
| 2026-02-25 | Huller Kelly | officer: EVP, GC, Corporate Secretary | SELL | 20,000 | $94.50 | $1.9M |
| 2026-02-12 | Huller Kelly | officer: EVP, GC, Corporate Secretary | SELL | 10,000 | $87.67 | $877K |
| 2026-02-12 | Huller Kelly | officer: EVP, GC, Corporate Secretary | M-Exempt | 10,000 | $45.64 | $456K |
| 2026-01-21 | Pfeil Keith W | director, officer: President, CEO | A-Award | 100,000 | $94.15 | $9.4M |
| 2026-01-21 | Wolterman Dan | director | A-Award | 15,000 | $94.15 | $1.4M |
| 2026-01-21 | Davidar David D | director | A-Award | 15,000 | $94.15 | $1.4M |
| 2026-01-21 | Huller Kelly | officer: EVP, GC, Corporate Secretary | A-Award | 40,000 | $94.15 | $3.8M |
| 2026-01-21 | Kline Kyle | officer: Senior Vice President, CFO | A-Award | 30,000 | $94.15 | $2.8M |
| 2026-01-21 | ZARRILLI STEPHEN T | director | A-Award | 15,000 | $94.15 | $1.4M |
| 2026-01-21 | Norwalk Leslie V | director | A-Award | 15,000 | $94.15 | $1.4M |
| 2026-01-21 | TOBIN JAMES R | director | A-Award | 15,000 | $94.15 | $1.4M |
| 2026-01-21 | DeFord John A | director | A-Award | 15,000 | $94.15 | $1.4M |
| 2026-01-21 | Paul David C | director, 10 percent owner, officer: Executive Chairman | A-Award | 100,000 | $94.15 | $9.4M |
| 2026-01-21 | Douglas Robert Andrew | director | A-Award | 15,000 | $94.15 | $1.4M |
| 2026-01-21 | Lemaitre Dan | director | A-Award | 15,000 | $94.15 | $1.4M |
| 2026-01-21 | RHOADS ANN D | director | A-Award | 15,000 | $94.15 | $1.4M |
| 2026-01-08 | Kline Kyle | officer: Senior Vice President, CFO | SELL | 3,594 | $101.10 | $363K |
| 2026-01-08 | Kline Kyle | officer: Senior Vice President, CFO | M-Exempt | 3,594 | $51.87 | $186K |